Amoéba S.A. (FRA:A1H)

Market Cap	55.45M +20.8%
Revenue (ttm)	n/a
Net Income	-8.30M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,347
Average Volume	910
Open	0.7710
Previous Close	0.8500
Day's Range	0.7710 - 0.7790
52-Week Range	0.7710 - 1.3360
Beta	n/a
RSI	36.23
Earnings Date	Apr 17, 2026

About Amoéba

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is based in Chassieu, France.

• Industry: Miscellaneous Chemical Products
• Founded: 2010
• Employees: 20
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A1H